시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 쌍태아 수혈 증후군 치료 시장 보고서(2025년)
Twin-Twin Transfusion Syndrome Treatment Global Market Report 2025
상품코드 : 1751147
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

쌍태아 수혈 증후군 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.8%의 CAGR(연평균 성장률)로 10억 달러 규모에 이를 것으로 예상됩니다. 예측 기간 동안의 성장은 인식 개선 및 조기 진단, 최소침습적 시술의 사용 증가, 모체 태아 의학에 대한 관심 증가, 유전자 검사 및 위험 평가의 사용 확대, TTTS의 유병률 증가 등 여러 가지 요인에 기인합니다. 이 기간의 주요 동향으로는 최소침습 수술, 인공지능과 기계학습의 적용, 산전 모니터링 및 진단의 발전, 유전자 편집 및 줄기세포 치료, 수술 및 치료 개입의 개선 등이 있습니다.

다태임신의 증가가 쌍둥이 수혈 증후군 치료 시장의 성장을 견인할 것으로 예상됩니다. 다태임신은 쌍둥이, 세쌍둥이, 고위험 다태아 등 여러 태아를 임신하는 것으로, 주로 난소를 자극하여 여러 개의 난자를 방출하도록 하는 불임 치료로 인해 다태임신이 보편화되고 있습니다. 쌍둥이 수혈 증후군 치료는 공유 태반의 비정상적인 혈관 연결을 해결하고 태아 간의 균형 잡힌 혈류 회복을 돕습니다. 이를 통해 쌍둥이의 생존율을 크게 향상시키고 합병증 위험을 줄일 수 있습니다. 예를 들어, 2023년 9월 호주에 기반을 둔 연구 기관인 Twins Research Australia는 호주에서 4,118건의 다태아 출산이 기록되어 호주 전체 출생 건수 28만 6,998건의 1.5%를 차지했다고 보고했습니다. 이 중 쌍둥이가 4,073건(약 99%)으로 대부분을 차지했으며, 세쌍둥이 이상의 다태아는 45건(1%)에 불과했습니다. 결과적으로 다태아 임신의 증가가 쌍둥이-쌍둥이 간 수혈 증후군 치료 수요를 견인하고 있습니다.

쌍태아 수혈 증후군 치료 시장의 주요 기업들은 첨단 치료 솔루션의 개발 및 상용화를 가속화하기 위해 전략적 파트너십에 집중하고 있습니다. 전략적 파트너십은 공동의 사업 목표를 위해 노력하는 독립적인 조직 간의 장기적인 협력 관계입니다. 이러한 접근 방식을 통해 각 당사자는 서로의 강점, 자원 및 시장 도달 범위를 활용할 수 있습니다. 예를 들어, 2023년 1월 CHA 할리우드 장로교 의료센터(미국)는 로스엔젤레스 태아 외과(미국)와 협력하여 획기적인 태아 수술 프로그램을 시작했습니다. 미국에서 몇 안 되는 이 프로그램은 척추이분증, 쌍둥이 수혈 증후군과 같은 심각한 질환을 가진 태아에게 최소침습적 치료를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Twin-twin transfusion syndrome (TTTS) treatment involves specialized medical procedures to address the blood flow imbalance between monochorionic twins who share a single placenta. The primary treatment is fetoscopic laser photocoagulation, which seals abnormal blood vessel connections to restore balanced circulation. Additional interventions may include amnioreduction to alleviate excess amniotic fluid or early delivery in severe cases.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main treatment options for twin-twin transfusion syndrome include laser therapy, surgery, blood transfusion, and medication. Laser therapy utilizes focused light to close abnormal blood vessel connections between the twins, helping to restore balanced blood flow. Diagnosis is made using various methods, including ultrasound, blood tests, and amniocentesis. The treatment is delivered through different routes, such as injectable, oral, and others, to address symptoms such as breathlessness, abdominal tightness, rapid abdomen expansion, rapid weight gain, stomach pressure, and premature contractions. It is used by a range of end-users, including hospitals, homecare services, specialty clinics, and others.

The twin-twin transfusion syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides twin-twin transfusion syndrome treatment market statistics, including the twin-twin transfusion syndrome treatment industry global market size, regional shares, competitors with the twin-twin transfusion syndrome treatment market share, detailed twin-twin transfusion syndrome treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the twin-twin transfusion syndrome treatment industry. This twin-twin transfusion syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The twin-twin transfusion syndrome treatment market size has grown strongly in recent years. It will grow from$0.72 billion in 2024 to $0.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to several factors, including increased awareness of TTTS risk factors in multiple gestations, the growing customization of treatment plans based on twin type, the rising use of targeted therapies for complications, the expanding role of patient-reported outcomes in TTTS management, and heightened awareness and education for expectant parents.

The twin-twin transfusion syndrome treatment market size is expected to see strong growth in the next few years. It will grow to$1.00 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth during the forecast period can be attributed to several factors, including rising awareness and early diagnosis, the increasing use of minimally invasive procedures, a growing focus on maternal-fetal medicine, the expanding use of genetic testing and risk assessment, and the rising prevalence of TTTS. Key trends during this period include minimally invasive surgery, the application of artificial intelligence and machine learning, advancements in prenatal monitoring and diagnostics, gene editing and stem cell therapies, and improvements in surgical and therapeutic interventions.

The growing number of multiple pregnancies is expected to drive the growth of the twin-twin transfusion syndrome treatment market. Multiple pregnancies, where a woman carries more than one fetus, such as twins, triplets, or higher-order multiples, are becoming more common, primarily due to fertility treatments that stimulate the ovaries to release multiple eggs. Twin-twin transfusion syndrome treatment addresses abnormal blood vessel connections in the shared placenta, helping to restore balanced blood flow between the fetuses. This significantly increases the chances of survival and reduces the risk of complications for both twins. For example, in September 2023, Twins Research Australia, a research institute based in Australia, reported that Australia recorded 4,118 multiple births, which accounted for 1.5% of the country's total 286,998 births. Among these, twins represented the majority, with 4,073 cases (about 99%), while only 45 births (1%) involved triplets or higher-order multiples. As a result, the rise in multiple pregnancies is driving the demand for twin-twin transfusion syndrome treatments.

Leading companies in the twin-twin transfusion syndrome treatment market are focusing on strategic partnerships to accelerate the development and commercialization of advanced therapeutic solutions. A strategic partnership is a long-term collaboration between independent organizations working toward shared business objectives. This approach enables each party to leverage mutual strengths, resources, and market reach. For example, in January 2023, CHA Hollywood Presbyterian Medical Center, a US-based healthcare provider, partnered with Los Angeles Fetal Surgery, a US-based medical clinic, to launch a groundbreaking life-saving fetal surgery program. This initiative, one of the few in the U.S., offers minimally invasive treatments for unborn babies with severe conditions, including spina bifida and twin-twin transfusion syndrome.

In December 2024, Umarji Hospital, an India-based provider of treatment for twin-to-twin transfusion syndrome, joined forces with the Society of Fetal Medicine to promote fetal therapy excellence in India. The collaboration seeks to advance fetal care in India through hands-on training and expert-led knowledge exchange. This partnership, which focuses on complex conditions such as twin-twin transfusion syndrome, aims to enhance procedural expertise and improve prenatal outcomes by fostering innovation, simulation, and multidisciplinary learning. The Society of Fetal Medicine, based in India, is dedicated to advancing fetal care through education and research.

Major players in the twin-twin transfusion syndrome treatment market are Mayo Foundation for Medical Education and Research, USF Health, Johns Hopkins Medicine, University Hospitals, Seattle Children's Hospital, Texas Children's Hospital, Cincinnati Children's Hospital Medical Center, Apollo Hospitals, Tampa General Hospital, Children's Hospital Colorado, Medicover Hospitals, UCSF Health, King's College Hospital, The Children's Hospital of Philadelphia, Riley Children's Health, Yale School of Medicine, Brown University Health, Society for Maternal-Fetal Medicine, Lurie Children's Hospital, Rainbow Children's Hospital, UNC Department of Obstetrics & Gynecology.

North America was the largest region in the twin-twin transfusion syndrome treatment market in 2024. The regions covered in twin-twin transfusion syndrome treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the twin-twin transfusion syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The twin-twin transfusion syndrome treatment market consists of revenues earned by entities by providing services such as amnioreduction, maternal-fetal consultation, and emergency delivery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The twin-twin transfusion syndrome market includes sales of amniocentesis kits, fetal monitoring systems, selective cord coagulation instruments, and genetic testing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Twin-Twin Transfusion Syndrome Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on twin-twin transfusion syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for twin-twin transfusion syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The twin-twin transfusion syndrome treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Twin-Twin Transfusion Syndrome Treatment Market Characteristics

3. Twin-Twin Transfusion Syndrome Treatment Market Trends And Strategies

4. Twin-Twin Transfusion Syndrome Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Twin-Twin Transfusion Syndrome Treatment Growth Analysis And Strategic Analysis Framework

6. Twin-Twin Transfusion Syndrome Treatment Market Segmentation

7. Twin-Twin Transfusion Syndrome Treatment Market Regional And Country Analysis

8. Asia-Pacific Twin-Twin Transfusion Syndrome Treatment Market

9. China Twin-Twin Transfusion Syndrome Treatment Market

10. India Twin-Twin Transfusion Syndrome Treatment Market

11. Japan Twin-Twin Transfusion Syndrome Treatment Market

12. Australia Twin-Twin Transfusion Syndrome Treatment Market

13. Indonesia Twin-Twin Transfusion Syndrome Treatment Market

14. South Korea Twin-Twin Transfusion Syndrome Treatment Market

15. Western Europe Twin-Twin Transfusion Syndrome Treatment Market

16. UK Twin-Twin Transfusion Syndrome Treatment Market

17. Germany Twin-Twin Transfusion Syndrome Treatment Market

18. France Twin-Twin Transfusion Syndrome Treatment Market

19. Italy Twin-Twin Transfusion Syndrome Treatment Market

20. Spain Twin-Twin Transfusion Syndrome Treatment Market

21. Eastern Europe Twin-Twin Transfusion Syndrome Treatment Market

22. Russia Twin-Twin Transfusion Syndrome Treatment Market

23. North America Twin-Twin Transfusion Syndrome Treatment Market

24. USA Twin-Twin Transfusion Syndrome Treatment Market

25. Canada Twin-Twin Transfusion Syndrome Treatment Market

26. South America Twin-Twin Transfusion Syndrome Treatment Market

27. Brazil Twin-Twin Transfusion Syndrome Treatment Market

28. Middle East Twin-Twin Transfusion Syndrome Treatment Market

29. Africa Twin-Twin Transfusion Syndrome Treatment Market

30. Twin-Twin Transfusion Syndrome Treatment Market Competitive Landscape And Company Profiles

31. Twin-Twin Transfusion Syndrome Treatment Market Other Major And Innovative Companies

32. Global Twin-Twin Transfusion Syndrome Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Twin-Twin Transfusion Syndrome Treatment Market

34. Recent Developments In The Twin-Twin Transfusion Syndrome Treatment Market

35. Twin-Twin Transfusion Syndrome Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기